PGE2 targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction
- 28 August 2011
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 307 (2), 227-236
- https://doi.org/10.1016/j.canlet.2011.04.008
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 36 references indexed in Scilit:
- Genetic Interaction of PGE2 and Wnt Signaling Regulates Developmental Specification of Stem Cells and RegenerationCell, 2009
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Cyclooxygenases, prostanoids, and tumor progressionCancer and Metastasis Reviews, 2007
- Prostaglandin E2 Regulates the Nuclear Receptor NR4A2 in Colorectal CancerJournal of Biological Chemistry, 2006
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2005
- Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2005
- Prostaglandin E2 Synergistically Enhances Receptor Tyrosine Kinase-dependent Signaling System in Colon Cancer CellsPublished by Elsevier BV ,2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Prostaglandin E2concentrations in naturally occurring canine cancerProstaglandins, Leukotrienes & Essential Fatty Acids, 2001
- EpiregulinPublished by Elsevier BV ,1995